BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 5476825)

  • 21. [Adrenergic response during neuroleptoanalgesia. Studies on the mechanism of catecholamine release].
    Herbaczyńska-Cedro K; Staszewska-Barczak J
    Acta Physiol Pol; 1972; 23(5):751-60. PubMed ID: 4645105
    [No Abstract]   [Full Text] [Related]  

  • 22. [Breathing control in neuroleptoanalgesia].
    Herbaczyńska-Cedro K
    Acta Physiol Pol; 1972; 23(3):379-92. PubMed ID: 5035534
    [No Abstract]   [Full Text] [Related]  

  • 23. [Neuroleptoanalgesia for thyroid gland surgery].
    Butrov AV
    Eksp Khir Anesteziol; 1972; 17(1):68-72. PubMed ID: 5053342
    [No Abstract]   [Full Text] [Related]  

  • 24. [Our experience with neuroleptoanalgesia].
    Pallini C
    Minerva Anestesiol; 1965 Dec; 31(12):659-64. PubMed ID: 5882841
    [No Abstract]   [Full Text] [Related]  

  • 25. [Some new blocking drugs in surgical treatment of hyperthyroidism].
    Tobik S; Dyaczyńska A
    Wiad Lek; 1971 Apr; 24(8):791-2. PubMed ID: 5577771
    [No Abstract]   [Full Text] [Related]  

  • 26. [Considerations on neuroleptoanalgesia and its practical applications].
    Benini G
    Acta Anaesthesiol; 1966; 17():Suppl 1:103-26. PubMed ID: 6014332
    [No Abstract]   [Full Text] [Related]  

  • 27. [Is it possible to operate on noncompensated hyperfunctioning goiter?].
    CzyzewSKI K; Bielicki F; Zagrobelny Z
    Cas Lek Cesk; 1968 Dec; 107(50):1523-5. PubMed ID: 5711203
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of drugs used in neuroleptoanalgesia on bile duct pressure].
    Uray E; Kósa C
    Anaesthesist; 1969 Mar; 18(3):74-7. PubMed ID: 5359867
    [No Abstract]   [Full Text] [Related]  

  • 29. [Enzymatic changes in anesthesia with penthrane and neuroleptoanalgesia of type 2].
    Cassina I; Pannacciulli E; Trazzi R
    Minerva Anestesiol; 1967 Oct; 33(10):761-4. PubMed ID: 5611101
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of myocardial infarction with agents used in type II (NLA II) neuroleptoanalgesia.
    Kaniak J; Suchnicka R; Zagrobelny Z
    Pol Med Sci Hist Bull; 1969 Apr; 12(2):79-83. PubMed ID: 5770246
    [No Abstract]   [Full Text] [Related]  

  • 31. [Neuroleptoanalgesia: changes of ocular and systemic pressures].
    Rosignoli PJ; Goldman E
    Medicina (B Aires); 1966; 26(6):329-34. PubMed ID: 5999103
    [No Abstract]   [Full Text] [Related]  

  • 32. [The induction phase of neuroleptoanalgesia].
    Poledna M; Hirsch A; Scheinarová A; Kofanová T
    Rozhl Chir; 1968 Aug; 47(8):535-9. PubMed ID: 5682085
    [No Abstract]   [Full Text] [Related]  

  • 33. [In vitro O 2 consumption of heart muscle slices of rats injected with Inoval].
    Machado SC; Marques M
    Rev Bras Anestesiol; 1971; 21(1):73-9. PubMed ID: 5096268
    [No Abstract]   [Full Text] [Related]  

  • 34. [A case of pheochromocytoma operated on in emergency under neuroleptoanalgesia type II (NLA II)].
    Kaniak J; Kuczyńska-Sekieta K; Skóra K; Suchnicki Z; Zagrobelny Z
    Pol Tyg Lek; 1969 Apr; 24(15):602-3. PubMed ID: 5801924
    [No Abstract]   [Full Text] [Related]  

  • 35. [Adrenergic response during neuroleptoanalgesia. Release of catecholamines].
    Herbaczyńska-Cedro K; Staszewska-Barczak J
    Acta Physiol Pol; 1972; 23(5):735-49. PubMed ID: 4645104
    [No Abstract]   [Full Text] [Related]  

  • 36. [Neuroleptoanalgesia: influence on intra-operative bleeding and protection against hemorrhagic shock].
    Allegreni R; Iantorno F
    Arch Ortop; 1966; 79(1):29-35. PubMed ID: 5959669
    [No Abstract]   [Full Text] [Related]  

  • 37. [Does neuroleptoanalgesia effectively protect against shock?].
    Mosca A
    Minerva Anestesiol; 1967 Jan; 33(1):47-9. PubMed ID: 5596008
    [No Abstract]   [Full Text] [Related]  

  • 38. [The antiarrhythnic action of fentanest and of dehydrobenzoperidol (experimental research)].
    Molinaroli P; Ruggerini R; Romagna R
    Minerva Anestesiol; 1967 May; 33(5):403-7. PubMed ID: 5605169
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of myocardial infarction with agents used in neuroleptoanalgesia type II (NLA II)].
    Kaniak J; Suchnicka R; Zagrobelny Z
    Pol Tyg Lek; 1969 Apr; 24(15):592-5. PubMed ID: 5801922
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neuroleptoanalgesia].
    De Blasi A; Appiani L; Brienza A; Gasparetto A; Manni C; Maritano M; Mazzarella B; Morpurgo V
    Minerva Anestesiol; 1968 Aug; 34(8):933-90. PubMed ID: 5736580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.